Previous 10 | Next 10 |
ACB, ADBE, FDX, ISR, SFIX For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Tuesday's close
Are These Cheap Penny Stocks To Buy Or Avoid? Making money with penny stocks is something that has influenced millions of traders around the world. Thanks to big breakouts in stocks like AMC, GME, and, most recently, CEI, traders are getting a taste of just what penny stocks are capable...
RICHLAND, Wash, Sept. 09, 2021 (GLOBE NEWSWIRE) -- – Isoray , Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, today announced that it will host a conference call to discuss ...
Isoray (ISR) posted a slide in its fiscal third-quarter revenue, as the company dealt with weak performance from its core prostate brachytherapy business.Revenue for the third quarter declined 10% to $2.60M versus $2.88M last year, beating analysts' estimate by $0.19M.The company, howeve...
Revenue Increased 10% Sequentially Record Non-Prostate Brachytherapy Revenue Increased 20% Year-Over-Year RICHLAND, Wash., May 13, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expandin...
RICHLAND, Wash., April 29, 2021 (GLOBE NEWSWIRE) -- Isoray , Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, today announced that it will host a conference call to discuss its financial ...
RICHLAND, Wash., April 13, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator, today announced that Donna Fort has been appointed Vice President, Sales and Marketing. CEO Lori Woods said Fort’s appointment add...
RICHLAND, Wash., March 31, 2021 (GLOBE NEWSWIRE) -- A recently published small prospective series of patients with recurrent head and neck (H&N) cancers treated with surgical resection and Isoray’s Cesium-131 brachytherapy found potential benefits that support further research in...
The following slide deck was published by IsoRay, Inc. in conjunction with this event. For further details see: IsoRay (ISR) Investor Presentation - Slideshow
Penny Stocks Trading Higher As $1,400 Stimulus Checks Roll Out Despite the market’s hesitation before the Fed meeting today, penny stocks have remained a broad focus for traders. These highly volatile shares trade for less than $5 and continue attracting swing traders and day...
News, Short Squeeze, Breakout and More Instantly...
IsoRay Inc. Company Name:
ISR Stock Symbol:
NYSE Market:
RICHLAND, Wash. and CORALVILLE, Iowa, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (formerly known as Isoray, Inc.) (NYSE AMERICAN: ISR), a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents and an innovator in seed b...
C omp any’s focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies New corporate tagline and website introduced N ew ticker symbol to be NYSE American: CATX RICHLAND,...
The combination delivers the promise of bringing powerful new perspectives to the rapidly emerging field of Alpha-Particle radiopharmaceuticals Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced the successful complet...